Uncovering Line Of Therapy (LoT) Insights for Improved HCP Engagement
This is a members only resource. If you would like to learn more about PMSA membership, click here.
We will convene one or more life science analytics experts to explore the advantages of using commercial and Medicare data to understand patient journeys. The experts focused on cancer care/rare disease will discuss insights gained from time-based analysis and use it to find newly diagnosed patients and patients where disease progression has required changes in LoT.
The webinar will discuss the following questions:
- Why is it important to follow the patient journey:
- From pre-Medicare eligible to Medicare eligible?
- From the first line of treatment to later lines of therapy?
- How to evaluate the drugs in the market basket?
- What’s the lookback period?
- What are your best practices for asserting with combos or line switching?
- How to leverage data to better manage provider outreach?
- Ashish Patel, Chief Growth Officer and co-founder, CareSet
- Amy Bamford, Business Development Director, CareSet
- Tom Boulay, Deciphera, Senior Director of Commercial Insights